Table 2

Summary of LTK consultations by school term

School termSeasonN total consultationsN (%) eligible for RDT (i.e., reporting fever +1 relevant symptom)*N (%) tested with RDT†N (%) confirmed malaria positive by RDT‡[test positivity rate]N (%) treated with AL§ [% of confirmed cases treated]
Dec-Mar 2014¶Rainy12 6549074 (71.7)9909 (78.3)7651 (60.5) [77.2]7388 (58.5) [96.6]
May-Jul 2014Post-rainy56654154 (73.3)4503 (79.5)3678 (64.9) [81.7]3535 (62.4) [96.1]
Sept-Nov 2014Dry57722996 (51.9)3510 (60.8)2068 (35.8) [58.9]1956 (33.9) [94.6]
Dec-Mar 2015Rainy85945082 (59.1)5608 (65.3)4157 (48.4) [74.1]3876 (45.1) [93.2]
Totals32 68521 306 (65.2)23 530 (72.0)17 554 (53.7) [74.6]16 755 (51.3) [95.4]
  • Total number of unique consultations, number eligible (ie, reporting relevant symptoms) for an RDT, number tested by RDT, number testing malaria-positive by RDT, number treated with ACT for RDT and tested by RDT; displayed as a percentage of all unique consultations. Numbers in square brackets denote test positivity rate and percentage of confirmed cases treated.

  • *Includes those eligible for RDT who reported fever plus any of headache, vomiting, diarrhoea, dehydration, nausea, stomach ache, weakness and cough; excludes those eligible for RDT who reported fever plus only general aches, muscle/joint pains or loss of appetite.

  • †Includes those tested in the absence of fever plus one other relevant symptom (n=2969, 12.6%) and those presumed to be tested by RDT—where RDT results are recorded but data for RDT performed are missing (n=187, 0.6%).

  • ‡Includes those presumed to be positive by RDT—where RDT was performed and treatment was recorded but data for RDT results are missing .

  • §Includes those treated in the absence of RDT conducted, and those treated with RDT-negative result.

  • ¶Includes consultations conducted in November 2013 (n=499).

  • AL, artemether lumefantrine; LTK, Learner Treatment Kit; RDT, rapid diagnostic test.